Navigation Links
ePharmaSolutions Announces the Deployment of its Enterprise Clinical Trial Portal for Two Global Biopharmaceutical Companies
Date:8/24/2011

CONSHOHOCKEN, Pa., Aug. 24, 2011 /PRNewswire/ -- ePharmaSolutions announced the successful deployment of its Enterprise level Clinical Trial Portal (CTP) for a top five global pharmaceutical company on more than 900 studies to 90 countries and a second client deployment scheduled for September 2011.

Clinical Trial Portals help streamline and accelerate the clinical development process for sponsors, study sites and third party vendors by providing a common technology platform from which to conduct their trials.  Historically these portals were deployed at the study level, resulting in measurable improvements in time and cost for that study.  Today, biopharmaceutical companies are standardizing on single vendors to provide these portal solutions across the enterprise to help realize the time and cost savings across the enterprise while simplifying the process for study teams and site users.

"We are seeing more of our sponsors and CRO partners migrate from single study workspaces to enterprise CTP deployments this year than ever," stated Lance Converse, ePharmaSolutions' Founder and CEO.  "Enterprise deployments of the CTP help force the standardization of business processes across the clinical development lifecycle while reducing cost and accelerating timelines," added Converse.

ePharmaSolutions' Clinical Trial Portal is currently used by more than 235,000 users in 120 countries and helps biopharmaceutical companies improve and accelerate site activation, study training, safety letter distribution, and patient recruitment while integrating all of the third-party vendor applications (EDC, IXRS, Labs, etc.) to help centralize study management/reporting and provide users with one website and one set of credentials for all of their clinical study needs.

"Enterprise deployments typically include integrations with the clients' CTMS, EDC and IXRS systems, which can significantly reduce the amount of data entry required across the various systems used to conduct trials in today's technology driven clinical trials environment," stated Steven Beales, ePharmaSolutions Vice President of Information Technology.  "The integrations allow the study teams to add or edit a user in the CTP and authenticate that change to all of the systems used in the study, eliminating redundant manual data entry and multiple account registrations forms," Beales added.

The typical cost saving for using the Clinical Trial Portal on a one year 75 site global oncology study can exceed $1 million dollars (US) when compared to the traditional cost of paper based site feasibility, study document completion, in-person training and overnighted safety letter distribution.

About ePharmaSolutions

ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals.   ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology and has activated and trained more than 235,000 clinical researchers in 120 countries for the top 20 pharmaceutical companies in the world.  ePharmaSolutions is headquartered in Philadelphia with offices in London. For more information visit www.epharmasolutions.com or call Lance Converse at 610-832-9915.  Follow us on LinkedIn and Facebook.


'/>"/>
SOURCE ePharmaSolutions
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ePharmaSolutions Clinical Trial Investigator Portal Wins Bio-IT World 2009 Best Practice Award
2. ePharmaSolutions Launches New Version of Electronic Monitor Visit Report Application With Industry-Leading Online and Offline Capabilities
3. ePharmaSolutions Launches Major Release of Its Global Safety Letter Distribution and Tracking Application in More Than 90 Countries
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/7/2017)... IRVING, Texas , Oct. 6, 2017   ... industry with more than $100 billion in purchasing power, ... industry news and information. The Newsroom is ... chain and industry trends, infographics, expert bios, news releases, ... Besides having access to a wealth of resources at ...
(Date:10/4/2017)... Centers for Disease Control and Prevention (CDC), influenza vaccination should take ... communities across Massachusetts , Connecticut , ... through the end of the month. *Some exclusions apply ... ... by the end of October, according to the Centers for Disease Control ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... one of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. ... awards program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at ...
(Date:10/12/2017)... ... October 12, 2017 , ... In the United ... year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and ... havens have extremely low property-tax rates, which contributes to the relatively lower cost ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... at the University of California Berkeley, and other leading institutions in announcing the ... power of institutions to change the way animals are raised for food. , ...
(Date:10/12/2017)... San Antonio, Texas (PRWEB) , ... October 12, ... ... medical device and biologics manufacturer, has expanded its executive staff with the addition ... Development. , In this role, Slott will develop the national distribution and sales ...
Breaking Medicine News(10 mins):